FDA Approved: FENOFIBRATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

This FDA entry records Cipla USA Inc.'s original approval of a generic fenofibrate tablet for lipid disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Combined Hyperlipidemia
• Hyperlipidemia
• Hypertriglyceridemia
• Mixed Dyslipidemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

ORIG AP for FENOFIBRATE (FENOFIBRATE)